Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies

Journal of Neurology

Volumn 258, Issue 5, 2011, Pages 746-752

  Cenacchi, Giovanna ^a   Valentina, Papa ^a   Marina, Fanin ^b   Elena, Pegoraro ^b   Corrado, Angelini ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

AChR positive myasthenia gravis; Mitochondria; MuSK positive myasthenia gravis; Transmission electron microscopy

Indexed keywords

CHOLINERGIC RECEPTOR; MUSCLE SPECIFIC RECEPTOR TYROSINE KINASE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MITOCHONDRIAL MYOPATHY; MITOCHONDRION SWELLING; MUSCLE ATROPHY; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; PRIORITY JOURNAL; TISSUE STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; YOUNG ADULT;

EID: 79959919709     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5823-x     Document Type: Article

References (36)

1. Drachman DB (1994) Myasthenia gravis. N Engl J Med 330:1797-1810
2. Keesey JC (2004) Clinical evaluation and management of myasthenia gravis. Muscle Nerve 29:484-505 (Pubitemid 38451340)
3. Angelini C (1994) Miastenia grave: progressi clinici. Piccin Editor, pp 209-220
4. Jaretski III, Bahron RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Neurology 55:16-23 (Pubitemid 30460991)
5. Mossman S, Vincent A, Newsom-Davis J (1986) Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity. Lancet 1:116-119
6. Hoch W, McConville J, Helms J et al (2001) Auto-antibodies to the receptor tyrosin-kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365-368 (Pubitemid 32224355)
7. Nemoto Y, Kuwabara S, Misawa N et al (2005) Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry 76:714-718 (Pubitemid 40569685)
8. Rostedt Punga A, Ahlqvist K, Bartoccioni E et al (2006) Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Clin Neurophysiol 117:1434-1443 (Pubitemid 43947705)
9. DeChiara TM, Bowen DC, Valenzuela DM et al (1996) The receptor tyrosin kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85:501-512 (Pubitemid 26157189)
10. Deymeer F, Gungor-Tuncer O, Yilmaz V et al (2007) Clinical comparison of anti-MuSK vs anti-AChR-positive and seronegative myasthenia gravis. Neurology 68:609-611
11. Romi F, Aarli, Gilhus NE (2005) Seronegative myasthenia gravis: disease severity and prognosis. Eur J Neurol 12:413-418 (Pubitemid 40768658)
12. Guptill JT, Sanders DB (2010) Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis. Curr Opin Neurol 23:530-535
13. Sanders DB, El-Salem K, Massey JM et al (2003) Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60:1978-1980 (Pubitemid 36736017)
14. Martignago S, Fanin M, Albertini E et al (2009) Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR. Neuropathol Appl Neurobiol 35:103-110
15. Farrugia ME, Robson MD, Clover L et al (2006) MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Brain 129:1481-1492 (Pubitemid 43999381)
16. Selcen D, Fukuda T, Shen XM et al (2004) Are MuSK antibodies the primary cause of myasthenic symptoms? Neurology 62:1945-1950 (Pubitemid 38738201)
17. Niks EH, Kuks JBM, Wokke JHJ et al (2010) Pre-postsynaptic neuromuscular junction abnormalities in MuSK. Myasthenia Muscle Nerve 42:283-288
18. Vincent A (2008) Autoimmune disorders of the neuromuscular junction. Neurol India 56:305-313
19. Shiraishi H, Motomura M, Yoshimura T et al (2005) Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann Neurol 57:289-293 (Pubitemid 40179868)
20. Wang Q, Zhang B, Xiong WC et al (2006) MuSK signalling at the neuromuscular junction. J Mol Neurosci 30:223-226
21. Benveniste O, Jacobson L, Farrugia ME et al (2005) MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscles in vivo. J Neuroimmunol 170:41-48 (Pubitemid 41740905)
22. Farrugia ME, Bonifati DM, Clover L et al (2007) Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. J Neuroimmunol 185:136-144 (Pubitemid 46497437)
23. Caress JB, Hunt CH, Batish SD (2005) Anti-MuSK myasthenia gravis presenting with purely ocular findings. Arch Neurol 62:1002-1003 (Pubitemid 40973464)
24. Hain B, Hanisch F, Deschauer M (2004) Seronegative myasthenia with antibodies against muscle-specific tyrosin kinase. Nervenartz 75:362-367 (Pubitemid 38552506)
25. Lavrnic D, Losen M, Vujic A et al (2005) The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiat 76:1099-1102 (Pubitemid 41081284)
26. Stickler DE, Massey JM, Sanders DB (2005) MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns. Clin Neurophysiol 116:2065-2068 (Pubitemid 41262197)
27. Soltys J, Gong B, Kaminski HJ et al (2008) Extraocular muscle susceptibility to myasthenia gravis. Unique immunological environment? Ann N Y Acad Sci 1132:220-224 (Pubitemid 351841377)
28. Yu Wai Man CY, Chinnery PF, Griffiths PG (2005) Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscul Disord 15:17-23 (Pubitemid 41556628)
29. Dupuis L, Gonzales de Aguilar JL, Echaniz-Laguna A et al (2009) Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. Plos One 4:e5390
30. Xu K, Jha S, Hoch W, Dryer SE (2006) Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis. Neuroscience 143:655-659 (Pubitemid 44751373)
31. MacAskill AF, Rinholm JE, Twelvetrees AE et al (2009) Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondrial at synapses. Neuron 61:541-555
32. Pesce V, Cormio A, Fracasso F et al (2001) Age-related mitochondrial genotypic and phenotypic alterations in human skeletal muscles. Free Rad Biol Med 30:1223-1233 (Pubitemid 32463933)
33. Dobbins GC, Luo S, Yang Z et al (2008) Alpha-actinin interacts with rapsyn in agrin-stimulated AChR clustering. Mol Brain 1(1):18
34. Spillane J, Beeson DJ, Kullmann DM (2010) Myasthenia and related disorders of the neuromuscular junction. J Neurol Neurosurg Psychiatry 81:850-857
35. Vincent A, Leite MI (2005) Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 18:519-525 (Pubitemid 41476137)
36. Vincent A, Bowen J, Newsom-Davis J et al (2003) Seronegative generalised myasthenia gravis: clinical features, antibodies, and their target. Lancet Neurol 2:99-106 (Pubitemid 37443330)